We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYLO
7251
DELISTED
Xylo Technologies
XYLO
$4K ﹤0.01%
12
-25
-68% -$8.55K
GPUS
7252
Hyperscale Data Inc
GPUS
$55.4M
0
PFIE
7253
DELISTED
Profire Energy, Inc
PFIE
$4K ﹤0.01%
1,775
-5,132
-74% -$7.63K
ASXC
7254
DELISTED
Asensus Surgical, Inc.
ASXC
$4K ﹤0.01%
192
+134
+231% +$1.56K
DLA
7255
DELISTED
Delta Apparel Inc.
DLA
$4K ﹤0.01%
174
-2,001
-92% -$41.3K
ENG
7256
DELISTED
ENGlobal Corp
ENG
$4K ﹤0.01%
376
ESEB
7257
DELISTED
Xtrackers J.P. Morgan ESG Emerging Markets Sovereign ETF
ESEB
$4K ﹤0.01%
168
+18
+12% +$450
BPTH
7258
DELISTED
Bio-Path Holdings Inc
BPTH
$4K ﹤0.01%
+3
New +$4.11K
MDVL
7259
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$4K ﹤0.01%
+5
New +$4.73K
IMBI
7260
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$4K ﹤0.01%
333
-29
-8% -$298
AMBC.WS
7261
DELISTED
Ambac Financial Group
AMBC.WS
$4K ﹤0.01%
+431
New +$3.85K
AGRX
7262
DELISTED
Agile Therapeutics
AGRX
$4K ﹤0.01%
1
IEA
7263
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$4K ﹤0.01%
400
-200
-33% -$1.97K
CTEK
7264
DELISTED
CynergisTek, Inc.
CTEK
$4K ﹤0.01%
+1,054
New +$4.29K
BDR
7265
DELISTED
Blonder Tongue Laboratories Inc
BDR
$4K ﹤0.01%
9,323
+7,991
+600% +$4.16K
GGO
7266
DELISTED
The Gabelli Go Anywhere Trust
GGO
$4K ﹤0.01%
247
+99
+67% +$1.69K
MLPI
7267
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
$4K ﹤0.01%
175
-1,073
-86% -$27.3K
CORV
7268
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$4K ﹤0.01%
2,162
+1,562
+260% +$5.31K
URR
7269
DELISTED
Market Vectors Double Long Euro ETN
URR
$4K ﹤0.01%
211
-89
-30% -$1.68K
MTFBW
7270
DELISTED
Motif Bio plc Warrants to Purchase ADRs
MTFBW
$4K ﹤0.01%
1,210
-1,800
-60% -$3.98K
DNBF
7271
DELISTED
DNB Financial Corp
DNBF
$4K ﹤0.01%
103
-194
-65% -$6.48K
RVEN
7272
DELISTED
Reven Housing REIT, Inc.
RVEN
$4K ﹤0.01%
749
+362
+94% +$1.82K
ROX
7273
DELISTED
Castle Brands, Inc.
ROX
$4K ﹤0.01%
+2,957
New +$4.72K
NVLN
7274
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$4K ﹤0.01%
536
+509
+1,885% +$4.08K
EGI
7275
DELISTED
Entre Resources Ltd. Common Shares
EGI
$4K ﹤0.01%
8,102
-48,354
-86% -$21.7K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.